Journal article
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: Protocol for a systematic review and network meta-analysis
S Cortese, N Adamo, C Mohr-Jensen, AJ Hayes, S Bhatti, S Carucci, C Del Giovane, LZ Atkinson, T Banaschewski, E Simonoff, A Zuddas, C Barbui, M Purgato, HC Steinhausen, F Shokraneh, J Xia, A Cipriani, D Coghill
BMJ Open | BMJ PUBLISHING GROUP | Published : 2017
Abstract
Introduction Attention-deficit/hyperactivity disorder (ADHD) is a major public health issue. Pharmacological treatments play an important role in the multimodal treatment of ADHD. Currently, there is a lack of up-to-date and comprehensive evidence on how available ADHD drugs compare and rank in terms of efficacy and tolerability, in children or adolescents as well as in adults. We will conduct a network meta-analysis (NMA), integrating direct and indirect comparisons from randomised controlled trials (RCTs), to rank pharmacological treatments for ADHD according to their efficacy and tolerability profiles. Methods and analysis We will search a broad range of electronic databases, including Pu..
View full abstractGrants
Funding Acknowledgements
This project is supported by Stichting Eunethydis (European Network for Hyperkinetic Disorder) Foundation. The European ADHD Guidelines Group (EAGG) is working group of Eunethydis. No input from external funders was provided.